SEAN BODIN: Open Payments
NPI 1841799939 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,510 in 97 payments from 20 companies in 2025. Trend: 2023 $1,832 · 2024 $1,805 · 2025 $1,510
Food & beverage: $1,510
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $295 |
| AstraZeneca Pharmaceuticals LP | 5 | $189 |
| Abbott Laboratories | 9 | $173 |
| PFIZER INC. | 19 | $168 |
| Otsuka America Pharmaceutical, Inc. | 9 | $157 |
| Novo Nordisk Inc | 9 | $153 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Lundbeck LLC | 2 | $45 |
| Lilly USA, LLC | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $38 |
Products named: FREESTYLE LIBRE 3, FARXIGA, VRAYLAR, REXULTI, Ozempic, QULIPTA, PREVNAR 20, NURTEC ODT.
Industry payments across VA — which companies pay providers there.
